Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Here’s Why Investors Should Avoid Ambarella Stock for Now

By Larry Ramer, InvestorPlace Contributor
Ambarella and AMBA stock have great potential, but now is not the time for investors to pull the trigger on the name.

Software-maker Splunk Stock Looks Splendid Ahead of Earnings

By Chris Markoch, InvestorPlace Contributor
The more Splunk stock falls during this market selloff, the more opportunity investors have to grab the next leg up of its rally.

iBio Pharma Stock: 8 Things for Investors to Know as Shares Soar 181%

By William White, InvestorPlace Writer
iBio Pharma (IBIO) stock is blasting off on Friday as fears of the coronavirus from China continue to grow and it works on a vaccine.

“Zoom Stock” Confusion Causes Investors to Put Stock in Wrong Company

By William White, InvestorPlace Writer
Both Zoom Video Communications (ZM) and Zoom Technologies (ZOOM) are on the move Friday following some Zoom stock confusion.

Altimmune News: ALT Stock Rockets 110% on Coronavirus Vaccine News

By William White, InvestorPlace Writer
Altimmune (ALT) news for Monday includes positive news about a vaccine to treat the coronavirus from China have ALT stock soaring higher.

Wayfair Earnings: W Stock Walloped 13% by Q4 Profit Miss

By William White, InvestorPlace Writer
Wayfair (W) earnings for the online furniture retailer's fourth quarter of 2019 have W stock suffering a defeat on Friday.

Will Advanced Micro Devices Stock Recover From This Month’s Selloff?

By Brad Moon, InvestorPlace Contributor
Advanced Micro Devices took a hit in Monday’s coronavirus selloff, with AMD stock dropping 7.8%, but that doesn’t make it a bargain.

Look Anywhere but Acasti Pharma Stock for Opportunity

By Thomas Niel, InvestorPlace Contributor
It doesn't look good for Acasti Pharma stock. If they plan on doubling-down on CaPre, they need more capital. A dilutive equity raise would push shares down further. Even if they do a reverse stock split. Yet, shares aren't guaranteed to hit zero. If their subsequent actions with CaPre pay off, shares could soar as the prospective drug gets back on track.

E.W. Scripps Earnings: SSP Stock Slips 2% Despite Q4 Beat

By William White, InvestorPlace Writer
E.W. Scripps (SSP) earnings for the broadcasting company's fourth quarter of 2019 have SSP stock sliding lower on Friday.

Despite Market Correction, Luckin Stock Remains Hot

By Nicolas Chahine, InvestorPlace Contributor
LK stock has so far outperformed Starbucks and the S&P 500 in this market correction. So the upside opportunities outweigh the downside risk.

Foot Locker Earnings: FL Stock Flies 11% Higher on Q4 Topper

By William White, InvestorPlace Writer
Foot Locker (FL) earnings for the athletic wear retailer's fourth quarter of 2019 have FL stock taking off Friday on an EPS beat.

Coronavirus Hasn’t “Maxed Out” MA Stock Just Yet

By Josh Enomoto, InvestorPlace Contributor
It's no surprise MA stock tumbled alongside the wider markets, but hold off buying into Mastercard; coronavirus is only getting started.

Traders Are Treating Inovio Like 2018’s Pot Stock Stars

By Dana Blankenhorn, InvestorPlace Contributor
Inovio is working on a long-shot vaccine against China's coronavirus and traders are treating INO stock like a true star.

What to Expect From Hewlett Packard Q1 Earnings

By Brad Moon, InvestorPlace Contributor
With HPE stock down 23% over past 12 months, server sales down, and coronavirus panic, don’t expect good news when HPE reports Q1 earnings.

Roku Stock Looks Attractive Here, but Mind the Key Risk

By Vince Martin, InvestorPlace Contributor
After a pullback, the valuation of Roku stock seems more reasonable relative to other growth names. However, a long-term risk remains.

Inovio’s Coronavirus Vaccine Makes INO Stock Worth a Bet

By Chris Lau, InvestorPlace Contributor
Speculators are betting that INO stock and its vaccine are coronavirus killers, but the biotechnology firm may be more than just that.

There Is No Good Play When It Comes to INO Stock

By Thomas Niel, InvestorPlace Contributor
With this in mind, what's the best play? Stay on the sidelines. INO stock is too overvalued to go long. But, unpredictability makes it a weak short candidate. Staying on the fence may be the best move.

Despite Job Cuts, GE Stock Has Long, Hard Climb Back To $20 

By Will Ashworth, InvestorPlace Contributor
General Electric cut its global workforce by 78,000 employees in 2019. Is that good news or bad news for GE stock?

Baidu Earnings: BIDU Stock on the Move After Reporting Q4 Results

By William White, InvestorPlace Writer
Baidu (BIDU) earnings for the Chinese tech company's fourth quarter of 2019 have BIDU stock up after markets closed on Thursday.
Load More Articles